Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A – Bloomberg

Medivation Inc. (MDVN), which has already quadrupled in a year, is still tempting acquirers with a prostate cancer treatment that’s poised to make it one of the world’s fastest-growing drug developers. Shares of the San Francisco-based …

Posted in Uncategorized